Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

COVID-19 may trigger hair loss conditions like alopecia areata.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Environmental factors can trigger alopecia areata in identical twins.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Older men's scalp damage increases with age and sun exposure, a baby girl in the Philippines has Schimmelpenning syndrome, and thyroid screening is advised for children with hair loss and certain risk factors.

Premature hair graying in young men is linked to family history, obesity, and smoking.

A new mutation in the STS gene causes X-linked ichthyosis, even in rare female cases.

A new EDA gene variant causes X-linked hypohidrotic ectodermal dysplasia in a Chinese family.

Delayed puberty often runs in families, can affect growth, and may need hormone treatment.

Early detection and treatment of Menkes disease with copper injections are crucial for better outcomes.

The baby's rash and hair loss were cured with zinc supplements and better skin care.

The 7-month-old boy has a persistent rash that doesn't improve with typical skin treatments.

Eating vegetarian, having allergies, and family history might be linked to getting gray hair early.

Melanocytes are destroyed by factors needed for melanin production, causing vitiligo and gray hair.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Men with sleep apnea and low iron levels are more likely to have male-pattern baldness, especially if they have a family history of hair loss.

Children with alopecia areata often face neglectful parenting, leading to higher anxiety and depression.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Excessive hair loss can be an early sign of celiac disease.